Budesonide: Clinical Trials

76 trials of Budesonide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 10 terminated, 4 unknown, 4 withdrawn. 76 Phase 2, 11 Phase 3, 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 276Completed 51, Terminated 10, Unknown 4, Withdrawn 4, Active not recruiting 3, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1
Phase 311Completed 8, Enrolling by invitation 1, Terminated 1, Withdrawn 1
Phase 110Completed 4, Terminated 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1

Follow Budesonide: new trials by email Literature Review of Budesonide trials Research Report on Budesonide

Trials (filtered) newest first · largest first

All 76 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Little Lungs Study
Calfactant, Budesonide - Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome
Phase 1 / Phase 2Not yet recruitingUniversity of Wisconsin, Madison242027-02-012026-11-02
Efficacy and Safety of CP006 Inhalation Powder in Participants With Asthma
Budesonide, Formoterol Fumarate, and Umeclidinium Bromide, Budesonide and Formoterol Fumarate, Placebo for CP006 Inhalation Powder - Asthma
Phase 2CompletedShanghai Xin Huanghe Pharmaceutical Co., Ltd.1502025-11-212026-09-08
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Lunsekimig, Short-Acting Beta Agonists (SABA), Placebo - Asthma
Phase 2Active not recruitingSanofi5562024-11-072026-09-22
Nasal Obstruction With Oxymetazoline and Corticosteroids
Oxymetazoline Nasal Spray, Budesonide nasal spray - Nasal Obstruction
Phase 2RecruitingWashington University School of Medicine802024-10-152025-09-11
Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum
budesonide, omeprazole (proton pump inhibitor) - Crohn Disease (CD)
Phase 2 / Phase 3Enrolling by invitationMedical University of Warsaw1142024-07-302024-12-06
CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma
Salbutamol, Fluticason either Beclometasone or Budesonide - Asthma
Phase 2UnknownUniversità degli Studi di Ferrara802024-06-182024-07-03
Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis
Budesonide MMX®, Budesonide controlled ileal release (CR) capsules - Microscopic Colitis
Phase 2Active not recruitingUniversity of Calgary802024-03-212026-10-21
Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant
Budesonide EC, Placebo - Multiple Myeloma, Plasma Cell Leukemia
Phase 2RecruitingUniversity of Utah1202023-05-032026-06-05
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
Smell Retraining, Budesonide - Dysosmia, Anosmia
Phase 1 / Phase 2TerminatedAmanda Stapleton202021-09-302024-06-13
Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics
AQ001S 0.125 mg/ml, Budesonide 0.125 mg/ml inhalation suspension - Asthma
Phase 1 / Phase 2CompletedAquilon Pharmaceuticals S.A.232021-07-232024-09-03
Coronavirus Smell Therapy for Anosmia Recovery
Budesonide, High-Concentration Essential Oil, Placebo - Anosmia
Phase 2WithdrawnWashington University School of Medicine2021-06-012021-03-02
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Ibrutinib, ECG, PFT's - Chronic GVHD
Phase 2CompletedNational Cancer Institute (NCI)102021-05-102026-01-23
The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis
Budesonide, Prednisone, Saline - Chronic Rhinosinusitis With Nasal Polyps
Phase 2 / Phase 3CompletedKafrelsheikh University1202021-05-012023-07-05
STerOids in COVID-19 Study
Budesonide dry powder inhaler - Coronavirus Infection
Phase 2TerminatedUniversity of Oxford1462020-07-162021-02-08
Therapeutic Approaches to Malnutrition Enteropathy
Colostrum high protein powder (Neovite), N-Acetyl Glucosamine (GInNAC), Teduglutide - Severe Acute Malnutrition
Phase 2CompletedQueen Mary University of London1252020-05-042021-09-27
Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
Budesonide, Placebo, Nebulizer - Acute Respiratory Distress Syndrome
Phase 2TerminatedThe University of Texas Health Science Center, Houston22020-02-042022-07-13
Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)
Nitric Oxide, Budesonide - Chronic Sinusitis
Phase 2CompletedSanotize Research and Development corp.562019-10-272022-06-30
Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
Budesonide in bovine lipid extract surfactant (BLES) - Bronchopulmonary Dysplasia, Respiratory Distress Syndrome in Premature Infant
Phase 1 / Phase 2UnknownUniversity of Manitoba302019-10-152019-07-17
Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates
Budesonide - Chronic Sinus Infection, Chronic Sinusitis
Phase 2 / Phase 3WithdrawnKaiser Permanente2019-08-132021-01-14
Inhaled Steroids for Acute Pharyngitis.
Budesonide 0.25 MG/ML Inhalant Solution, Dexamethasone, Normal saline - Acute Pharyngitis
Phase 2 / Phase 3CompletedOman Medical Speciality Board2002019-06-012022-07-11

Showing 20 of 76. Sign in to see all of them.

Conditions studied

Asthma (13)  ·  Eosinophilic Esophagitis (6)  ·  Pulmonary Disease, Chronic Obstructive (5)  ·  Respiratory Distress Syndrome (4)  ·  Bronchopulmonary Dysplasia (3)  ·  Crohn Disease (3)  ·  Rhinitis, Allergic, Seasonal (3)  ·  Sinusitis (3)  ·  Anosmia (2)  ·  Bronchiolitis Obliterans (2)  ·  COVID-19 (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Colitis, Ulcerative (2)  ·  Diarrhea (2)  ·  Gastroesophageal Reflux (2)

Sponsors

AstraZeneca (7)  ·  Dr. Falk Pharma GmbH (5)  ·  Mayo Clinic (4)  ·  Syntara (3)  ·  Ligand Pharmaceuticals (2)  ·  National Cancer Institute (NCI) (2)  ·  Pari Pharma GmbH (2)  ·  Sanofi (2)  ·  Washington University School of Medicine (2)  ·  ALK-Abelló A/S (1)  ·  Activaero GmbH (1)  ·  Allergan (1)  ·  Amanda Stapleton (1)  ·  Aquilon Pharmaceuticals S.A. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (29)  ·  Canada (13)  ·  Germany (12)  ·  United Kingdom (7)  ·  Poland (6)  ·  China (4)  ·  France (4)  ·  Italy (4)  ·  Sweden (4)  ·  Hungary (3)  ·  Spain (3)  ·  Australia (2)  ·  Belgium (2)  ·  Bulgaria (2)  ·  Denmark (2)

Top investigators

Bertil Andersson (2)  ·  Deepen Patel, MD (2)  ·  Abdullah A Alangari, MBBS (1)  ·  Adam M Zanation, MD (1)  ·  Alan James, MBBS (1)  ·  Alberto Papi, MD (1)  ·  Alex Straumann, MD (1)  ·  Alexander Gelbard, MD (1)  ·  Alvaro J Coronado Munoz, MD (1)  ·  Alvin Ing, MBBS (1)  ·  Amanda L Stapleton, MD (1)  ·  Amin Javer, MD (1)  ·  Amy Foxx-Orenstein, D.O. (1)  ·  Andrew Prendergast, PhD (1)

Results publications

PMID 16164444, PMID 17148626, PMID 17296644, PMID 18958997, PMID 18972276, PMID 20457157, PMID 20600032, PMID 20719253, PMID 21163939, PMID 22111863, PMID 23076943, PMID 23810723, PMID 24092567, PMID 24384609, PMID 24907502, PMID 25473939, PMID 25792708, PMID 25835160, PMID 26460293, PMID 28194229, PMID 28240689, PMID 28418482, PMID 28931508, PMID 29702300, PMID 31352415, PMID 31634236, PMID 31727642, PMID 3197368, PMID 32006953, PMID 32205633, PMID 32301783, PMID 32464281, PMID 32484940, PMID 32681228, PMID 32738928, PMID 32962709, PMID 33028169, PMID 33388170, PMID 33844996, PMID 35397798, PMID 35666852, PMID 36702070, PMID 37192443, PMID 38632262, PMID 38746861, PMID 40272745, PMID 8022437, PMID 8628614

NIH funding

2015 (3), UL1RR024150 (2), 2008 (1), 2009 (1), 2016 (1), KL2TR003168 (1), P30CA012197 (1)